NCT05747729 2023-02-28A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 1/2 Unknown60 enrolled